Many With Relapsed/Refractory Lymphoma in Pregnancy Delay Treatment
TUESDAY, June 6, 2023 -- Most women with relapsed/refractory lymphoma during pregnancy defer therapy and there are few obstetric or neonatal complications, according to a study published online June 1 in Blood Advances.
Faheem Farooq, M.D., from...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Lymphoma | OBGYN | Perinatology & Neonatology | Pharmaceuticals | Pregnancy | Study | Women